2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
43
Neoplasms
24
Motor Activity
12
Pain, Postoperative
9
Colorectal Neoplasms
9
Stomach Neoplasms
8
Lung Neoplasms
8
Fatigue
7
Anxiety Disorders
6
Pain
5
Carcinoma, Hepatocellular
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Leukemia, Myeloid, Acute
4
Depression
4
Colonic Neoplasms
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Sleep Initiation and Maintenance Disorders
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Malnutrition
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Interventions
Cisplatin
55
Carboplatin
49
pembrolizumab
42
Paclitaxel
42
Gemcitabine
28
Pemetrexed
23
Radiotherapy
21
Magnetic Resonance Spectroscopy
20
Radiotherapy, Intensity-Modulated
18
Cetuximab
18
Docetaxel
17
Specimen Handling
16
Nivolumab
16
Fluorouracil
16
Cyclophosphamide
14
durvalumab
13
Bevacizumab
13
Sorafenib
12
Radiation
11
Sunitinib
10
Platinum
10
130-nm albumin-bound paclitaxel
10
1,2-diaminocyclohexaneplatinum II citrate
10
osimertinib
9
Oxaliplatin
8
Irinotecan
8
Ipilimumab
8
Everolimus
8
Drug Therapy
8
Capecitabine
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma
×
Control Groups
×
Clear all
NCT04104334
2021-10-08
CHIPNOL
Ciusss de L'Est de l'Île de Montréal
Phase NA
Terminated
9 enrolled